DEF 14A

Company

SELLAS Life Sciences Group, Inc.

Filed

April 23, 2010

Period of Report

June 4, 2010

Accession Number

0000950123-10-037663

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →